help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirasawa, G.
Right arrow Articles by Krozowski, Z. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirasawa, G.
Right arrow Articles by Krozowski, Z. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 3 1306-1309
Copyright © 2000 by The Endocrine Society


Original Studies

11ß-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Placenta1

Gen Hirasawa2, Junji Takeyama, Hironobu Sasano, Kouhei Fukushima, Takashi Suzuki, Yasunari Muramatu, Andrew D. Darnel, Chika Kaneko, Nobuo Hiwatashi, Takayoshi Toyota, Hiroshi Nagura and Zygmunt S. Krozowski

Departments of Pathology (G.H., J.T., H.S., T.S., Y.M., A.D.D., C.K., H.N.), Internal Medicine (G.H., N.H., T.T.), and Surgery (K.F.), Tohoku University School of Medicine, Sendai, Miyagi 980-8575, Japan; and Laboratory of Molecular Hypertension, Baker Medical Research Institute (Z.S.K.), Melbourne 8008, Australia

Address correspondence and requests for reprints to: Junji Takeyama, M.D., Department of Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan. E-mail: j-takeyama{at}patholo2.med.tohoku.ac.jp

In mineralocorticoid target organs, 11ß-hydroxysteroid dehydrogenase type II (11ß-HSD2) confers specificity on the mineralocorticoid receptor (MR) by converting biologically active glucocorticoids to inactive metabolites. Placental 11ß-HSD2 is also thought to protect the fetus from high levels of circulating maternal glucocorticoid. In this study, we examined the immunoreactivity of 11ß-HSD2 and MR in human placenta from 5 weeks gestation to full term using immunohistochemistry, 11ß-HSD2 messenger RNA (mRNA) expression using Northern blot analysis, and MR mRNA expression using RT-PCR analysis. Marked 11ß-HSD2 immunoreactivity was detected in placental syncytiotrophoblasts at all gestational stages. MR immunoreactivity was moderately detected in syncytiotrophoblasts, some cytotrophoblasts, and interstitial cells of the villous core. Marked mRNA expression of 11ß-HSD2 was detected in placenta by Northern analysis. RT-PCR analysis of MR in placental tissues showed an amplified product consistent in length with the primers selected. These results suggest that placental 11ß-HSD2 is involved in not only regulating the passage of maternal active glucocorticoids into the fetal circulation but also in regulation of maternal-fetal electrolyte and water transport in the placenta, as in other mineralocorticoid target organs.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Naray-Fejes-Toth and G. Fejes-Toth
Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F486 - F494.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Y. Zhang, X. Ding, and R. A. Daynes
The Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type I by Lymphocytes Provides a Novel Means for Intracrine Regulation of Glucocorticoid Activities
J. Immunol., January 15, 2005; 174(2): 879 - 889.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P.M. Driver, S. Rauz, E.A. Walker, M. Hewison, M.D. Kilby, and P.M. Stewart
Characterization of human trophoblast as a mineralocorticoid target tissue
Mol. Hum. Reprod., December 1, 2003; 9(12): 793 - 798.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Sun and L. Myatt
Enhancement of Glucocorticoid-Induced 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Proinflammatory Cytokines in Cultured Human Amnion Fibroblasts
Endocrinology, December 1, 2003; 144(12): 5568 - 5577.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart
Expression of 11{beta}-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies
Mol. Hum. Reprod., April 1, 2001; 7(4): 357 - 363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society